Su, I.-C.; Su, Y.-K.; Setiawan, S.A.; Yadav, V.K.; Fong, I.-H.; Yeh, C.-T.; Lin, C.-M.; Liu, H.-W.
NADPH Oxidase Subunit CYBB Confers Chemotherapy and Ferroptosis Resistance in Mesenchymal Glioblastoma via Nrf2/SOD2 Modulation. Int. J. Mol. Sci. 2023, 24, 7706.
https://doi.org/10.3390/ijms24097706
AMA Style
Su I-C, Su Y-K, Setiawan SA, Yadav VK, Fong I-H, Yeh C-T, Lin C-M, Liu H-W.
NADPH Oxidase Subunit CYBB Confers Chemotherapy and Ferroptosis Resistance in Mesenchymal Glioblastoma via Nrf2/SOD2 Modulation. International Journal of Molecular Sciences. 2023; 24(9):7706.
https://doi.org/10.3390/ijms24097706
Chicago/Turabian Style
Su, I-Chang, Yu-Kai Su, Syahru Agung Setiawan, Vijesh Kumar Yadav, Iat-Hang Fong, Chi-Tai Yeh, Chien-Min Lin, and Heng-Wei Liu.
2023. "NADPH Oxidase Subunit CYBB Confers Chemotherapy and Ferroptosis Resistance in Mesenchymal Glioblastoma via Nrf2/SOD2 Modulation" International Journal of Molecular Sciences 24, no. 9: 7706.
https://doi.org/10.3390/ijms24097706
APA Style
Su, I.-C., Su, Y.-K., Setiawan, S. A., Yadav, V. K., Fong, I.-H., Yeh, C.-T., Lin, C.-M., & Liu, H.-W.
(2023). NADPH Oxidase Subunit CYBB Confers Chemotherapy and Ferroptosis Resistance in Mesenchymal Glioblastoma via Nrf2/SOD2 Modulation. International Journal of Molecular Sciences, 24(9), 7706.
https://doi.org/10.3390/ijms24097706